This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Adents, the leading provider of robust and easily deployable software solutions for serialization in the Life Sciences industry, has announced the opening of its second subsidiary in the North American market.
Driven by its firm reputation for successful deployments across Europe and the imminent implementation of the Drug Supply Chain Security Act (DSCSA), Adents today announced the opening of a new wholly owned subsidiary – Adents US Inc., in Princeton, USA, as the company continues with its major international expansion plan.
After the implantation of the French group in Montreal, Canada in October 2014, the company has installed a new office in Princeton, New Jersey. Adents expects to have 50 staff based in North America by the end of 2015.
Adents’ mature and robust software technology, which operates with all existing ERP systems and devices, is being introduced to the US market at a key time, as the DSCSA comes into force and many pharma companies and CMOs are still looking for an efficient, global solution which also responds to the immense challenges of data exchange and management.
Mr. Christophe Devins, CEO of Adents, is excited by the new development, “We are delighted about locating this strategic part of our business in Princeton and Montreal, platforms for the North American market, which accounts for over 40% of world-wide pharmaceutical sales. Adents USA will provide enhanced sales, marketing and customer support for our U.S. customer base.”
Adents will be increasingly present to expand its operations in North America, showcasing its Adents Pharma Suite solution at the 7th Pharmaceutical Packaging & Labelling USA in Philadelphia (25-26 February 2015), the Pharmaceutical Traceability Forum in Boston (30 March-1 April 2015) and Interphex in New York (21-23 April).
>> For more information, click here
